161 related articles for article (PubMed ID: 1385474)
1. Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors.
Pandrau D; Saeland S; Duvert V; Durand I; Manel AM; Zabot MT; Philippe N; Banchereau J
J Clin Invest; 1992 Nov; 90(5):1697-706. PubMed ID: 1385474
[TBL] [Abstract][Full Text] [Related]
2. Growth and maturation requirements of human B cell precursors.
Moreau I; Duvert V; Pandrau D; Banchereau J; Saeland S
Bone Marrow Transplant; 1992; 9 Suppl 1():68-71. PubMed ID: 1504673
[TBL] [Abstract][Full Text] [Related]
3. Functional effect of IL-7-enhanced CD19 expression on human B cell precursors.
Wolf ML; Weng WK; Stieglbauer KT; Shah N; LeBien TW
J Immunol; 1993 Jul; 151(1):138-48. PubMed ID: 7686930
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus.
Larson AW; LeBien TW
J Immunol; 1994 Jul; 153(2):584-94. PubMed ID: 7517420
[TBL] [Abstract][Full Text] [Related]
5. Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors.
Renard N; Duvert V; Blanchard D; Banchereau J; Saeland S
J Immunol; 1994 Feb; 152(4):1693-701. PubMed ID: 7509827
[TBL] [Abstract][Full Text] [Related]
6. Development of a bone marrow culture for maintenance and growth of normal human B cell precursors.
Wolf ML; Buckley JA; Goldfarb A; Law CL; LeBien TW
J Immunol; 1991 Nov; 147(10):3324-30. PubMed ID: 1719075
[TBL] [Abstract][Full Text] [Related]
7. Adherence of normal and neoplastic human B cell precursors to the bone marrow microenvironment.
Ryan DH
Blood Cells; 1993; 19(2):225-41; discussion 241-4. PubMed ID: 7906154
[TBL] [Abstract][Full Text] [Related]
8. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
Janssen O; Gillis S; Kabelitz D
Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
[TBL] [Abstract][Full Text] [Related]
9. Analysis of expression and function of CD40 on normal and leukemic human B cell precursors.
Law CL; Wörmann B; LeBien TW
Leukemia; 1990 Nov; 4(11):732-8. PubMed ID: 1700237
[TBL] [Abstract][Full Text] [Related]
10. Culture of human fetal B-cell precursors on bone marrow stroma maintains highly proliferative CD20dim cells.
Moreau I; Duvert V; Banchereau J; Saeland S
Blood; 1993 Mar; 81(5):1170-8. PubMed ID: 7680240
[TBL] [Abstract][Full Text] [Related]
11. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: dimethyl sulfoxide inhibits IL-6-induced differentiation of SKW6-CL4 into IgM-secreting plasma cells.
Teraoka H; Mikoshiba M; Takase K; Yamamoto K; Tsukada K
Exp Cell Res; 1996 Jan; 222(1):218-24. PubMed ID: 8549666
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effects of IL-4 on human B-cell response to IL-2.
Galanaud P; Karray S; Llorente L
Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of proliferative responses of human B cell precursor acute lymphoblastic leukemia (BCP-ALL) cells to interleukin 7 (IL-7): no correlation with immunoglobulin gene status and expression of IL-7 receptor or IL-2/IL-4/IL-7 receptor common gamma chain genes.
Smiers FJ; van Paassen M; Pouwels K; Beishuizen A; Hählen K; Löwenberg B; Touw IP
Leukemia; 1995 Jun; 9(6):1039-45. PubMed ID: 7596167
[TBL] [Abstract][Full Text] [Related]
14. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
15. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
[TBL] [Abstract][Full Text] [Related]
16. Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations.
Dworzak MN; Fritsch G; Fleischer C; Printz D; Fröschl G; Buchinger P; Mann G; Gadner H
Exp Hematol; 1998 Apr; 26(4):305-13. PubMed ID: 9546313
[TBL] [Abstract][Full Text] [Related]
17. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway. Antagonistic effect of anti-CD40 monoclonal antibody.
Dancescu M; Wu C; Rubio M; Delespesse G; Sarfati M
J Immunol; 1992 Apr; 148(8):2411-6. PubMed ID: 1373168
[TBL] [Abstract][Full Text] [Related]
18. Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors.
Wörmann B; Gesner TG; Mufson RA; LeBien TW
Leukemia; 1989 Jun; 3(6):399-404. PubMed ID: 2657229
[TBL] [Abstract][Full Text] [Related]
19. Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7.
Renard N; Duvert V; Matthews DJ; Pagés MP; Magaud JP; Manel AM; Pandrau-Garcia D; Philippe N; Banchereau J; Saeland S
Leukemia; 1995 Jul; 9(7):1219-26. PubMed ID: 7630198
[TBL] [Abstract][Full Text] [Related]
20. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
